The importance of TGF-β1 decreases with the tumour grade in high-grade gliomas (Jachimczak et al, 1996; Pan et al, 2006), and its expression does not correlate to time to progression (Hau et al, 2006). This evidence concerns the gene TGFB1 and central nervous system cancer.